Table 2. Clinical characteristics of the genotyped individuals.
| Parameters | African American | European American | American Indian | Mexican American |
| N | 954 | 614 | 781 | 1611 |
| Male | 324 (33.9%) | 276 (44.8%) | 298 (38.2%) | 686 (42.6%) |
| Age (years) | 59 (51, 67) | 62 (53, 70) | 53 (46, 61) | 57 (49, 65) |
| Diabetes duration (years) | 18 (11, 25) | 18 (11, 26) | 16 (4, 25) | 15 (7, 22) |
| BMI (kg/m2) | 32 (27, 37) | 30 (26, 36) | 32 (27, 37) | 30 (26, 34) |
| HbA1c (%) | 7.1 (6.2, 8.6) | 7.0 (6.2, 8.0) | 7.5 (6.3, 9.3) | 7.5 (6.4, 9.1) |
| Urine ACR (g/g) | 0.15 (0.01, 3.00) | 0.05 (0.01, 1.33) | 0.13 (0.02, 3.00) | 0.05 (0.01, 1.53) |
| Urine PCR (g/g) | 0.31 (0.06, 3.50) | 0.21 (0.06, 2.00) | 0.37 (0.09, 3.50) | 0.18 (0.05, 2.20) |
| eGFR (ml/min per 1.73 m2) | 46.6 (5.0, 83.0) | 52.2 (5.0, 77.9) | 60.5 (5.0, 97.4) | 69.1 (5.0, 100.3) |
ACR-Albumin:Creatinine Ratio; PCR-Protein:Creatinine Ratio; eGFR-estimated Glomerular Filtration Rate using modified MDRD equation Values are expressed as either N (%) or median (1st quartile, 3rd quartile).